{
  "id": 20313141,
  "title": "Helus Pharma notches successful Phase 3 depression readout",
  "url": "https://urgent.news/2026/11/16/helus-pharma-notches-successful-phase-3-depression-readout",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-16T18:30:34.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/helus-pharma-notches-successful-phase-3-depression-readout/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Helus Pharma, part of the budding class of psychedelics companies, said its lead drug improved depression symptoms compared to placebo, but investors appeared slightly skittish about the safety profile. The company said",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Helus Pharma to present Phase 3 depression trial results Monday",
        "url": "https://urgent.news/2026/11/15/helus-pharma-to-present-phase-3-depression-trial-results-monday",
        "published": "2026-11-15T17:04:37.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}